MedPath
NMPA Approval

Carbocysteine Oral Solution

国药准字H20247300

December 3, 2024

国药准字H20223415

Drug Information

羧甲司坦口服溶液

口服溶液剂

60毫升:3.0克

化学药品

December 3, 2024

Company Information

Applicant Company

广州市经济技术开发区东区东博路6号

Manufacturing Company

广州市经济技术开发区东区东博路6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

羧甲司坦口服溶液 - NMPA 批准文号 | MedPath